Vortex Liquid Biopsy Solutions

Vortex Liquid Biopsy Solutions is a biotechnology company focused on research and development in cancer diagnostics and personalized medicine. Based in Cambridge, UK, and the Bay Area, US, the company specializes in circulating tumor cell (CTC) capture technology. Their flagship product, the VTX-1 Liquid Biopsy System, is an automated benchtop instrument that isolates and purifies intact CTCs from whole blood samples using a proprietary microfluidic chip. This system achieves high cell recovery and purity, allowing for detailed analysis of cancer biomarkers. The company aims to enhance therapeutic decision-making and patient outcomes through a non-invasive method for routine CTC isolation. Their technology supports ongoing cancer monitoring via liquid biopsies, which are less invasive than traditional tissue biopsies. Vortex Liquid Biopsy Solutions serves an international customer base, including cancer researchers, clinical laboratories, and healthcare providers, facilitating companion diagnostics and targeted therapies to improve cancer patient care.

• Employees 5
• Founded 2012
• Annual Revenue $4000000
• Total Funding $4081888